Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...
Healthcare solutions provider Solventum (NYSE:SOLV) announced in Q4 CY2025, but sales fell by 3.7% year on year to $2.00 billion. Its GAAP profit of $0.36 per share was 37.3% below analysts’ consensus ...
Solventum beat estimated earnings by 4.67%, reporting an EPS of $1.57 versus an estimate of $1.5. Revenue was down $76.00 million from the same period last year. The company beat on EPS by $0.07 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results